A Prospective, Multicenter, Open-label, Comparative, Efficacy Study of Pegasys Plus Copegus in Treatment-naive Latino Patients With Chronic Hepatitis C-genotype 1, as Compared to Treatment-naive Non- Latino Caucasian Patients With Chronic Hepatitis C-genotype 1

Trial Profile

A Prospective, Multicenter, Open-label, Comparative, Efficacy Study of Pegasys Plus Copegus in Treatment-naive Latino Patients With Chronic Hepatitis C-genotype 1, as Compared to Treatment-naive Non- Latino Caucasian Patients With Chronic Hepatitis C-genotype 1

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Jun 2016

At a glance

  • Drugs Peginterferon alfa-2a; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms LATINO
  • Most Recent Events

    • 01 Jun 2010 Actual end date changed from Mar 2006 to Feb 2008 as reported by ClinicalTrials.gov.
    • 14 Jan 2009 Primary endpoint 'Sustained virological response rate' has been met.
    • 14 Jan 2009 Results published in the New England Journal of Medicine, according to 1020878.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top